Skip to main navigation Skip to search Skip to main content

Safety and immunogenicity of a homologous booster dose of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: 12 months follow-up result of an open-label, nonrandomized extension of a phase 1/2 trial

  • Joon Young Song
  • , Won Suk Choi
  • , Jung Yeon Heo
  • , Young Rong Kim
  • , Jin Soo Lee
  • , Dong Sik Jung
  • , Shin Woo Kim
  • , Kyung Hwa Park
  • , Joong Sik Eom
  • , Su Jin Jeong
  • , Jacob Lee
  • , Ki Tae Kwon
  • , Hee Jung Choi
  • , Jang Wook Sohn
  • , Young Keun Kim
  • , Yoonyeong Lee
  • , Ho Keun Park
  • , Ji Hwa Ryu
  • , Su Jeen Lee
  • , Yong Wook Park
    • Hun Kim, Francesca Solmi, Maria Angeles Ceregido, Marguerite Koutsoukos, Neil King, David Veesler, Hee Jin Cheong

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Safety and immunogenicity of a homologous booster dose of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: 12 months follow-up result of an open-label, nonrandomized extension of a phase 1/2 trial'. Together they form a unique fingerprint.
Sort by

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science